4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1-(pentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
95%
- Product Code: 61022
CAS:
212632-01-4
| Molecular Weight: | 407.51 g./mol | Molecular Formula: | C₂₃H₂₉N₅O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28387240 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound finds its primary application in the field of medicinal chemistry, where it is studied for its potential as a bioactive molecule. It is particularly investigated for its interactions with various receptors in the central nervous system, making it a candidate for the development of psychotropic drugs. Researchers are exploring its efficacy in modulating neurotransmitter systems, which could lead to treatments for psychiatric disorders such as anxiety, depression, and schizophrenia. Additionally, its structural features suggest potential use in the design of novel therapeutic agents targeting specific enzymes or proteins involved in disease pathways. Ongoing research aims to optimize its pharmacological properties for enhanced efficacy and reduced side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿67,500.00 |
+
-
|
4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1-(pentan-3-yl)-1H-1,2,4-triazol-5(4H)-one
This compound finds its primary application in the field of medicinal chemistry, where it is studied for its potential as a bioactive molecule. It is particularly investigated for its interactions with various receptors in the central nervous system, making it a candidate for the development of psychotropic drugs. Researchers are exploring its efficacy in modulating neurotransmitter systems, which could lead to treatments for psychiatric disorders such as anxiety, depression, and schizophrenia. Additionally, its structural features suggest potential use in the design of novel therapeutic agents targeting specific enzymes or proteins involved in disease pathways. Ongoing research aims to optimize its pharmacological properties for enhanced efficacy and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :